carboplatin

A platinum-containing anticancer agent much like cisplatin but more toxic to the myeloid elements of bone marrow while producing less nausea and neuro-, oto-, and nephrotoxicity; used in the chemotherapy of solid tumors.

* * *

car·bo·plat·in 'kär-bō-.plat-ən n a platinum-containing antineoplastic drug C₆H₁₂N₂O₄Pt that is an analog of cisplatin with somewhat reduced toxicity and that is used in the treatment of various cancers (as of the ovary or lung)

* * *

n.

a derivative of platinum that is used in the treatment of certain types of cancer (e.g. ovarian cancer). It is similar to cisplatin but has fewer side-effects; in particular, it causes less nausea and vomiting. Trade name: Paraplatin.

* * *

car·bo·pla·tin (kahrґbo-plat″in) [USP] a platinum coordination compound having the same mechanism of action as cisplatin, although its rate of action is slower and its spectrum of toxicity is different. Used in the treatment of ovarian carcinoma refractory to standard chemotherapy or in patients who cannot be safely treated with cisplatin; also used experimentally in the treatment of small and non–small cell lung carcinoma, head and neck carcinoma, testicular carcinoma, and seminoma. Administered intravenously.